Clinical Trial Update: Impact of TMP-SMX Prophylaxis on Malaria Infection and Immunity in Children in Uganda

View source ↗

Summary

A completed clinical trial evaluated the impact of TMP-SMX prophylaxis on malaria infection and immunity in Ugandan children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• TMP-SMX (trimethoprim-sulfamethoxazole) (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Malaria | Status: COMPLETED